Genomic Insight: How Jeff Ingersoll and Val Prisecaru Brought Practitioner Genomics Into Clinical Use
A practical look at the Diagnostic Solutions Lab GenomicInsight profile, the Opus23 informatics layer, and why this matters for practitioner-led precision health.
One of the clearest public examples of Jeff Ingersoll and Val Prisecaru working in the same precision-health lane is their January 2024 appearance on Dr. Ben Weitz's Rational Wellness Podcast. The episode framed Jeff as President of Diagnostic Solutions Lab and Val as a scientist connected to the development of the Opus23 platform used as the basis for Diagnostic Solutions Lab's GenomicInsight genomic health profile.
What they were discussing
Diagnostic Solutions Lab describes GenomicInsight as a genomic health profile powered by Opus23 Explorer. The company states that the platform allows clinicians to customize reports through an interactive dashboard that curates a patient's genomic data in real time using medical-literature databases and metadata sets. The test reports on more than 3,000 single nucleotide polymorphisms, or SNPs, in one functional DNA test.
That distinction matters. A raw DNA file is not automatically useful to a practitioner. The clinical value comes from translating variants into reportable themes, pathways, literature references, and practitioner-facing recommendations. Val's public background in nutrigenomics and multi-omics interpretation fits the science-translation side of that problem. Jeff's role at Diagnostic Solutions Lab connects that translation to a laboratory platform practitioners can actually order and use.
Why this is relevant to Studio23
Studio23 is built around the same broad clinical movement: helping practitioners move from isolated test results to usable biological context. Genomic testing is permanent context. It can inform risk, pharmacogenomics, nutrient pathways, methylation, detoxification, inflammation, and other systems that a practitioner may revisit over a patient's lifetime.
The most important practitioner lesson from their work is not simply that genomics is available. It is that genomics needs interpretation infrastructure. Clinicians need dashboards, curated evidence, report modules, and a workflow that lets them connect a patient's variants to care decisions without overclaiming what any single SNP can prove.
Impact from a practitioner perspective
- Jeff Ingersoll's contribution: public sources identify him as President of Diagnostic Solutions Lab, a company offering practitioner-facing functional and precision testing, including GenomicInsight and GI-MAP.
- Val Prisecaru's contribution: public sources describe him as a precision-health practitioner, nutrition scientist, educator, and nutrigenomics specialist with experience in glycomic, genetic, microbiome, and multi-omics analysis.
- The shared contribution: their joint podcast appearance centered on genomic testing as a clinical workflow, not as consumer curiosity.
